Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1801 to 1850 of 2518

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Preoperative high dose rate brachytherapy for rectal cancerIPG531
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapyTA352
Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)TA353
Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolismTA354
Antimicrobial stewardship: systems and processes for effective antimicrobial medicine useNG15
Infantile haemangioma: topical timololESUOM47
Visensia for early detection of deteriorating vital signs in adults in hospitalMIB36
Drug allergyQS97
Dyspepsia and gastro‑oesophageal reflux disease in adultsQS96
Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean sectionIPG528
Joint distraction for knee osteoarthritis without alignment correctionIPG529
Naloxegol for treating opioid‑induced constipationTA345
Aflibercept for treating diabetic macular oedemaTA346
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancerTA347
Everolimus for preventing organ rejection in liver transplantationTA348
Secukinumab for treating moderate to severe plaque psoriasisTA350
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal)TA351
Hypersexuality: fluoxetineESUOM46
BD MAX Enteric Bacterial Panel for identifying pathogens in contagious gastroenteritisMIB32
Spiral Flow peripheral vascular graft for treating peripheral arterial diseaseMIB34
Type 2 diabetes: insulin degludec/liraglutide (Xultophy)ESNM60
Symptoms of peripheral arterial disease: ramiprilESUOM45
Prevention of recurrence of C3 glomerulopathy post-transplant: eculizumabESUOM44
Electrotherapy for the treatment of haemorrhoidsIPG525
Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headacheIPG527
Insertion of an epiretinal prosthesis for retinitis pigmentosaIPG519
Radiofrequency ablation for gastric antral vascular ectasiaIPG520
Suture fixation of acute disruption of the distal tibiofibular syndesmosisIPG521
Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosisIPG523
Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolismIPG524
Personality disorders: borderline and antisocialQS88
Pressure ulcersQS89
Omalizumab for previously treated chronic spontaneous urticariaTA339
Vedolizumab for treating moderately to severely active ulcerative colitisTA342
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolismTA341
Lower urinary tract symptoms in men: managementCG97
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemiaTA343
Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challengesNG11
Violence and aggression: short-term management in mental health, health and community settingsNG10
Peptest for diagnosing gastro‑oesophageal refluxMIB31
LARS for reconstructing damaged intra-articular cruciate knee ligamentsMIB30
Xpert GBS test for the intrapartum detection of group B streptococcusMIB28
LipiFlow thermal pulsation treatment for dry eyes caused by blocked meibomian glandsMIB29
Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantationIPG516
Insertion of endobronchial nitinol coils to improve lung function in emphysemaIPG517
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetesIPG518
Smoking: reducing and preventing tobacco useQS82
Alcohol: preventing harmful use in the communityQS83
Physical activity: for NHS staff, patients and carersQS84
Medicines management in care homesQS85

Results per page

  1. 10
  2. 25
  3. 50
  4. All